SYQUANT CAPITAL SAS Quant / Systematic

Location: Paris, France

CIK: 0001766392 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Jan 10, 2024

Total Value: $22.16M

Holdings (7)

— MIRATI THERAPEUTICS INC 40.8%

Value $9.043M Shares 153,920 Est. Cost $58.75 Unrealized —

— LAZARD LTD 32.5%

Value $7.197M Shares 206,800 Est. Cost $34.80 Unrealized —

— ICOSAVAX INC 13.6%

Value $3.005M Shares 190,654 Est. Cost $15.76 Unrealized —

— KARUNA THERAPEUTICS INC 11.6%

Value $2.573M Shares 8,130 Est. Cost $316.48 Unrealized —

LOGI LOGITECH INTL S A 0.6%

Value $129K Shares 1,363 Est. Cost $79.67 Unrealized 0.0%

FRO FRONTLINE PLC 0.6%

Value $128K Shares 6,412 Est. Cost $18.20 Unrealized 0.0%

RACE FERRARI N V 0.4%

Value $82,000 Shares 243 Est. Cost $333.89 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	MIRATI THERAPEUTICS INC	153,920	$9.043M	40.8%	$58.75	—	—	60468T105
—	LAZARD LTD	206,800	$7.197M	32.5%	$34.80	—	—	G54050102
—	ICOSAVAX INC	190,654	$3.005M	13.6%	$15.76	—	—	45114M109
—	KARUNA THERAPEUTICS INC	8,130	$2.573M	11.6%	$316.48	—	—	48576A100
LOGI	LOGITECH INTL S A	1,363	$129K	0.6%	$79.67	0.0%	—	H50430232
FRO	FRONTLINE PLC	6,412	$128K	0.6%	$18.20	0.0%	—	M46528101
RACE	FERRARI N V	243	$82,000	0.4%	$333.89	0.0%	—	N3167Y103